Overview

Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Laval University
Treatments:
Bupivacaine
Hyaluronic Acid
Viscosupplements
Criteria
Inclusion Criteria:

- From 45 years old to 65 years old

- Clinically symptomatic moderate or severe hip osteoarthritis (Tönnis Grade II to III)

- Capacity to keep steady upright position and walking during 15 minutes

- Body mass index < 40kg/m2

Exclusion Criteria:

- Bilateral hip osteoarthritis

- No broken hip or leg during the last 12 months

- Bone necrosis

- Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis,
gout, active infection

- Per os corticosteroid treatment

- Corticosteroid injection < 3 months

- Viscosupplement injection < 6 months

- Hypersensitivity to hyaluronic acid products

- Planed surgery during study duration

- Physical or mental disability to fill in questionnaires and/or to participate to
follow-up